VILINBIO — Vilin Bio Med Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Vilin Bio Med, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IAS	IAS	IAS
Status:	Final	Final	Final
Revenue
Total Revenue	168	117	112
Cost of Revenue
Gross Profit	30.9	26.8	23.5
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	162	111	107
Operating Profit	5.88	6	5.47
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1.94	1.61	0.446
Provision for Income Taxes
Net Income After Taxes	1.62	1.21	0.335
Net Income Before Extraordinary Items
Net Income	1.62	1.21	0.335
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1.62	1.21	0.335
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.116	0.087	0.024
Dividends per Share